Cormorant Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $8.08M | Sell |
|
|||||
|
2023
Q4 | $13.5M | Hold |
|
|||||
|
2023
Q3 | $9.22M | Sell |
|
|||||
|
2023
Q2 | $17.3M | Hold |
|
|||||
|
2023
Q1 | $14.9M | Hold |
|
|||||
|
2022
Q4 | $17M | Hold |
|
|||||
|
2022
Q3 | $13.9M | Hold |
|
|||||
|
2022
Q2 | $12M | Hold |
|
|||||
|
2022
Q1 | $13.8M | Hold |
|
|||||
|
2021
Q4 | $19M | Sell |
|
|||||
|
2021
Q3 | $28.9M | Hold |
|
|||||
|
2021
Q2 | $42.9M | Sell |
|
|||||
|
2021
Q1 | $60.7M | Hold |
|
|||||
|
2020
Q4 | $75.1M | Hold |
|
|||||
|
2020
Q3 | $31.3M | Sell |
|
|||||
|
2020
Q2 | $30.7M | Sell |
|
|||||
|
2020
Q1 | $21.9M | Sell |
|
|||||
|
2019
Q4 | $41.8M | Sell |
|
|||||
|
2019
Q3 | $24.7M | Buy |
|
|||||
|
2019
Q2 | $31.1M | Buy |
|
|||||
|
2019
Q1 | $29.8M | Sell |
|
|||||
|
2018
Q4 | $28.8M | Buy |
|
|||||
|
2018
Q3 | $36.9M | Sell |
|
|||||
|
2018
Q2 | $29.8M | Sell |
|
|||||
|
2018
Q1 | $28.5M | Buy |
|